Alzinova AB
SEK3.37
0
+SEK0+0% Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
135.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
27OctConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.14
-0.12
-0.1
-0.08
Expected EPS
N/A
Actual EPS
-0.0855
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ALZ.ST. It's not an investment recommendation.
About
Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.
Show more...
CEO
Dr. Kristina Torfgard
Employees
3
Country
Sweden
ISIN
SE0007413455
WKN
000A2N87T